Amirayan N, Furrie E, Deleuil F, Mellor A, Leserman L, Machy P
Centre d'Immunologie INSERM-CNRS de Marseille-Luminy, France.
Immunology. 1995 Sep;86(1):71-8.
We have reported that class I- [and lymphocyte function-associated antigen-1 (LFA-1-)] specific monoclonal antibodies (mAb) inhibit anti-CD3-mediated activation of naive T cells. The present study investigated the mechanism of this inhibition. CD28-specific mAb augmented stimulation induced by soluble CD3 mAb, but this costimulation was also inhibited by anti-class I or anti-LFA-1 mAb. However, stimulation of T cells was not inhibited when activated B cells were present. Neither B7-1- nor B7-2-specific blocking mAb or soluble CTLA-4, CD40 or gp39 restored the inhibition. Thus, other molecules expressed on activated B cells are implicated for T-cell activation, which could compensate blockade of class I or LFA-1 molecules. Inhibition induced by class I-specific mAb could potentially be mediated through extracellular, transmembrane or cytoplasmic domains of the target molecules. These possibilities were evaluated by the use of mice transgenic for the Qa-2 molecule, selected for expression of Qa-2 at levels equivalent to classical class I molecules. Qa-2 is inserted in the membrane through phosphatidylinositol linkages. Antibodies directed to Qa-2 inhibited CD3-induced stimulation, demonstrating that cytoplasmic and transmembrane protein sequences of class I molecules are not necessary for the inhibitory effect. Inhibition thus presumably depends on extracellular domains. Finally, T cells from beta 2-microglobulin knock-out mice responded to CD3-specific mAb as well as their class I-positive littermates. Nevertheless, stimulation of T cells from these mice with mitogenic anti-Thy-1 mAb was markedly reduced. Signalling by Thy-1 and the CD3 complex may normally occur through pathways in which class I molecules are implicated.
我们曾报道,I类[以及淋巴细胞功能相关抗原-1(LFA-1-)]特异性单克隆抗体(mAb)可抑制抗CD3介导的初始T细胞活化。本研究探讨了这种抑制作用的机制。CD28特异性mAb增强了可溶性CD3 mAb诱导的刺激,但这种共刺激也被抗I类或抗LFA-1 mAb抑制。然而,当存在活化的B细胞时,T细胞的刺激并未受到抑制。B7-1或B7-2特异性阻断mAb或可溶性CTLA-4、CD40或gp39均不能恢复这种抑制作用。因此,活化B细胞上表达的其他分子参与了T细胞活化,这可能补偿了I类或LFA-1分子的阻断作用。I类特异性mAb诱导的抑制作用可能通过靶分子的细胞外、跨膜或胞质结构域介导。通过使用Qa-2分子转基因小鼠评估了这些可能性,这些小鼠被选择用于表达与经典I类分子水平相当的Qa-2。Qa-2通过磷脂酰肌醇连接插入膜中。针对Qa-2的抗体抑制了CD3诱导的刺激,表明I类分子的胞质和跨膜蛋白序列对于抑制作用并非必需。因此,抑制作用可能主要取决于细胞外结构域。最后,来自β2-微球蛋白基因敲除小鼠的T细胞对CD3特异性mAb的反应与其I类阳性同窝小鼠相同。然而,用促有丝分裂抗Thy-1 mAb刺激这些小鼠的T细胞时,反应明显降低。Thy-信号和CD3复合物信号通常可能通过涉及I类分子的途径发生。